Fc gamma R interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor model

Author(s):
Sow, H.S.; Benonisson, H.; Breukel, C.; Visser, R.; Verhagen, O.J.H.M.; Bentlage, A.E.H.; Brouwers, C.; Claassens, J.W.C.; Linssen, M.M.; Camps, M.; Hall, T. van (0000-0002-9115-558X); Ossendorp, F.; Fransen, M.F.; Vidarsson, G.; Verbeek, J.S.
Published
2019
Publication type
Article / Letter to editor
Fc gamma Ranti-PD-L1 mAb therapytumor microenvironment
Date issued
2019-01-15
Language
English
Is part of
International Journal of Cancer (2019), Vol. 144, no. 2, p. 345-354
hdl
1887/119503
doi
10.1002/ijc.31899